RELEASE: IRBM Expands Global Reach in Drug Discovery with New Office in Boston

(Information sent by the signatory company).

RELEASE: IRBM Expands Global Reach in Drug Discovery with New Office in Boston

(Information sent by the signatory company)

Strategic growth and increased visibility to enhance IRBM's leadership position

ROME, March 5, 2024 /PRNewswire/ -- IRBM, an integrated contract research organization (CRO) for drug discovery, announces its global expansion with a new office in Boston, Massachusetts, a cornerstone of biotechnology and drug discovery. This strategic initiative underscores IRBM's dedication to fostering innovation and collaboration within the life sciences sector, with the goal of leveraging Boston's dynamic biotechnology ecosystem for the accelerated development of therapies that address unmet medical needs across the world. larger scale.

By expanding IRBM's global reach, the Boston site will enhance direct interactions with partners, collaborators, and the broader scientific community in the United States and internationally. This move reinforces IRBM's mission to improve health outcomes through innovative research and an integrated, collaborative approach to drug discovery.

Matteo Liguori, CEO of IRBM, expressed his excitement about the expansion: "The opening of our first international office in Boston marks an important milestone in IRBM's journey, reflecting our commitment to advancing science and health at global scale. We are excited to be part of Boston's vibrant biotech ecosystem, which will help us facilitate new collaborations and accelerate our contributions to drug discovery and the scientific community."

In conjunction with the opening of the Boston office, IRBM is pleased to announce the launch of its redesigned website (, offering a more intuitive and user-friendly experience. The website provides detailed information about IRBM's research, capabilities and partnership opportunities, reflecting the company's efforts to enhance engagement with the global scientific community, partners and the public.

The introduction of IRBM's Boston office and the launch of its redesigned website signify significant advancements in the company's global reach and digital engagement. IRBM welcomes current and future collaborators and partners to schedule a visit to the new Boston location and explore the updated website, actions that underscore IRBM's commitment to advancing health through scientific innovation and partnership.

About IRBM

IRBM is a global leader in drug discovery and has a unique model to conduct all research at a single site, fostering unparalleled agility and efficiency from concept to candidate. This model facilitates rapid progress and minimizes setbacks. With a track record of contributing to four approved medicines, IRBM is driven by deep collaborations and decades of experience from leading global institutions. IRBM's comprehensive in-house capabilities help partners achieve key milestones and move toward clinical readiness, positioning them as a major player in driving innovation across the pharmaceutical and biotechnology industry.


Logo -

View original content: